SHEL.UK

3,209

-2.24%↓

BP

532.8

-2.47%↓

DCC

6,140

+0.16%↑

SHEL.UK

3,209

-2.24%↓

BP

532.8

-2.47%↓

DCC

6,140

+0.16%↑

SHEL.UK

3,209

-2.24%↓

BP

532.8

-2.47%↓

DCC

6,140

+0.16%↑

SHEL.UK

3,209

-2.24%↓

BP

532.8

-2.47%↓

DCC

6,140

+0.16%↑

SHEL.UK

3,209

-2.24%↓

BP

532.8

-2.47%↓

DCC

6,140

+0.16%↑

Home・Aandelen Lijst・Smith & Nephew PLC
Search

Smith & Nephew PLC

Gesloten

1,135.5 -0.48

Buy

Prijsupdate 12 jun 2026, 15:29 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1135

Max

1137.5

Belangrijke statistieken

By Trading Economics

Inkomsten

47M

342M

Verkoop

318M

3.3B

K/W

Sectorgemiddelde

21.306

63.807

EPS

0.429

Dividendrendement

3.43

Winstmarge

10.36

Werknemers

16,988

EBITDA

162M

886M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+23.74% upside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

3.43%

3.59%

Volgende Winsten

4 aug 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-1.4B

9.8B

Vorige openingsprijs

1135.98

Vorige sluitingsprijs

1135.5

Smith & Nephew PLC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

13 jun 2026, 23:52 UTC

China's House Price Index YoY release on June 16, 2026, faces cautious market sentiment amid ongoing declines and geopolitical tensions.

Lezen

13 jun 2026, 23:51 UTC

Correlated Moves

Bitcoin has advanced since Friday, reflecting positive sentiment in the cryptocurrency market. The asset remains below its 20-day moving average and near its one-month range low.

Lezen

13 jun 2026, 23:41 UTC

U.S. Stocks Surge on SpaceX IPO and Optimism Over U.S.-Iran Peace Talks, While Traders Anticipate Fed's Interest Rate Decision Amid Inflation Concerns.

Lezen

13 jun 2026, 23:41 UTC

U.S. Stocks Surge on Peace Deal Optimism, Fed Expected to Hold Rates Amid Geopolitical Tensions and Key Economic Data Ahead.

Lezen

13 jun 2026, 23:41 UTC

U.S. Stocks Surge on Peace Deal Optimism and Global Mineral Economy Shift Ahead of Steady Fed Rate Decision.

Lezen

13 jun 2026, 23:41 UTC

U.S. Stocks Surge on SpaceX IPO and Peace Deal Hopes, While Investors Brace for Key Economic Data and Fed Rate Decision.

Lezen

13 jun 2026, 23:41 UTC

Philadelphia Fed Manufacturing Index Release on June 18, 2026, Anticipates Growth Amid Mixed Economic Sentiment and Inflation Concerns.

Lezen

13 jun 2026, 23:31 UTC

U.S. Industrial Production MoM data for May 2026 expected to rise by 0.2% amid cautious optimism following April's strong performance of 0.7%.

Lezen

13 jun 2026, 23:21 UTC

U.S. Retail Sales MoM Report on June 17 Expected to Show Modest 0.5% Increase Amid Geopolitical Tensions and Consumer Spending Optimism

Lezen

13 jun 2026, 23:21 UTC

U.S. Retail Sales Ex Autos Expected to Rise 0.5% in May Amid Cautious Consumer Sentiment and Economic Resilience

Lezen

13 jun 2026, 23:21 UTC

Canada's New Housing Price Index set for June 17 release, with a forecasted slight decline amid ongoing affordability challenges and government announcements.

Lezen

13 jun 2026, 23:11 UTC

Market Anticipates U.S. Building Permits Data Release Amid Cautious Optimism and Economic Concerns on June 16, 2026.

Lezen

13 jun 2026, 23:02 UTC

India's RBI to release monetary policy meeting minutes amid lower-than-expected CPI inflation and rising food costs, influencing future interest rate decisions.

Lezen

13 jun 2026, 23:02 UTC

Upcoming U.S. Housing Starts Data Release on June 16, 2026 Expected to Reflect Economic Conditions Amid Government Initiatives and Rising Demand.

Lezen

13 jun 2026, 23:02 UTC

Investors Anticipate Further Increases in U.S. Export Prices Ahead of June 16 Release Amid Geopolitical Developments

Lezen

13 jun 2026, 23:02 UTC

U.S. Housing Starts Expected to Reach 1.44 Million Units in May Amid Mixed Trends and Policy Discussions Ahead of June 16 Release

Lezen

13 jun 2026, 23:02 UTC

U.S. Import Prices Report on June 16 Expected to Show 0.9% Increase Amid Geopolitical Optimism and Inflation Concerns

Lezen

13 jun 2026, 23:02 UTC

Market Anticipates 1.41 Million Building Permits in May 2026 Amidst Cautious Optimism for Housing Sector Recovery.

Lezen

13 jun 2026, 23:01 UTC

Macro News

DAX 30 Index rises in after-market trading amid optimism for a U.S.-Iran peace deal and President Trump's announcement on the Strait of Hormuz.

Lezen

13 jun 2026, 22:51 UTC

Japan's Year-on-Year Inflation Rate Release on June 18 Expected to Show Stability Amid Mixed Economic Signals and Global Influences.

Lezen

13 jun 2026, 22:51 UTC

Japan's Core Inflation Rate Expected to Hold at 1.4% Amid Cautious Market Sentiment and BOJ Policy Considerations

Lezen

13 jun 2026, 22:41 UTC

Market anticipates June 15 release of NY Empire State Manufacturing Index at 13.2, signaling cautious optimism amid inflation concerns and geopolitical developments.

Lezen

13 jun 2026, 22:41 UTC

Japan's Machinery Orders Expected to Rise 0.9% in April Amidst Mixed Economic Signals and Improving Investor Confidence

Lezen

13 jun 2026, 22:41 UTC

Japan's Exports Expected to Rise 0.162% YoY in June Amid Positive Economic Sentiment and Geopolitical Easing, Despite Competition from China

Lezen

13 jun 2026, 22:41 UTC

Mortgage Rates Set to Rise Amid Geopolitical Tensions and Economic Uncertainty, with Upcoming MBA Report Expected on June 17.

Lezen

13 jun 2026, 22:32 UTC

UK Consumer Confidence Index for June 2026 Forecasted at -23 Amid Ongoing Inflation and Economic Uncertainty

Lezen

13 jun 2026, 22:32 UTC

Canada's May 2026 Housing Starts Data Set for Release, Forecasted at 255K Units Amid Optimistic Market Sentiment and Government Initiatives.

Lezen

13 jun 2026, 22:32 UTC

Brazil's Central Bank to Provide Key Interest Rate Insights on June 15, Amidst Cautious Market Sentiment and Global Economic Influences.

Lezen

13 jun 2026, 22:32 UTC

Japan's trade deficit forecasted at -564.6 billion yen amid high import costs, but market optimism rises following easing U.S.-Iran tensions and strong Asian stock performance.

Lezen

13 jun 2026, 22:32 UTC

Brazil's Retail Sales Report on June 16 Expected to Show Resilience Amid Mixed Economic Signals

Lezen

Peer Vergelijking

Prijswijziging

Smith & Nephew PLC Prognose

Koersdoel

By TipRanks

23.74% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 1,402 GBX  23.74%

Hoogste 1,550 GBX

Laagste 1,300 GBX

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Smith & Nephew PLC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

6 ratings

3

Buy

3

Hold

0

Sell

Gebaseerd op 6 analisten die aandelenratings hebben gegeven aan Smith & Nephew PLC - Dist in de afgelopen 3 maanden.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Smith & Nephew PLC

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Andere aandelen uit de sector

SHEL.UK

Shell PLC

3,209

↓-2.24%

BPUS

BP PLC ADR

532.8

↓-2.47%

DCC

DCC PLC

6,140

↑ +0.16%
help-icon Live chat